Jinxia Wang - Shandong Weigao Independent Non-Executive Director
SHWGF Stock | USD 0.96 0.00 0.00% |
Director
Mrs. Wang Jin Xia is an Independent NonExecutive Director of Shandong Weigao Group Medical Polymer Company Limited. Mrs. Wang is a senior economist and has over 30 years of working experience especially the management experience in the pharmaceutical commerce pharmaceutical and healthcare products industry. Mrs. Wang obtained a bachelor degree in economics from Dongbei University of Finance and Economics in July 1983 and was assigned to work in State Pharmaceutical Administration of China Pharmaceutical Company. Mrs. Wang was deputy director of the finance division deputy director and director of the information division of China Pharmaceutical Company during the period from 1989 to 2002 and deputy secretary of China Pharmaceutical Business Association in 1999. Mrs. Wang was an independent director of Jiangsu Wu Zhong Industrial Company Limited a company listed in Shanghai from April 2002 to April 2010. Mrs. Wang held the positions of the general secretary and the vice president of China Association of Pharmaceutical Commerce and the person in charge of the pharmaceutical chains branch of China Association of Pharmaceutical Commerce from 2000 to 2012. She is also a senior advisor of China Nonprescription Medicines Association. Mrs. Wang is also an independent nonexecutive director of Shanghailisted Merro Pharmaceutical Co. Ltd since September 2007 and also the independent non executive director of Shandong Realcan Pharmaceutical Co. Ltd. a company listed in Shenzhen since November 2009. since 2012.
Age | 60 |
Tenure | 12 years |
Phone | 86 63 1562 1999 |
Web | https://www.weigaogroup.com |
Shandong Weigao Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Peter Henry | Citigroup | 51 | |
Christopher Jones | Becton Dickinson And | 65 | |
Amal Johnson | Intuitive Surgical | 65 | |
Andrew Eckert | Becton Dickinson And | 56 | |
Malcolm Pradhan | Alcon AG | N/A | |
Josh Puckridge | Alcon AG | N/A | |
Thomas Bahen | Alcon AG | N/A | |
Bertram Scott | Becton Dickinson And | 69 | |
Marshall Larsen | Becton Dickinson And | 72 | |
Mark Rubash | Intuitive Surgical | 61 | |
Luis Huete | Alcon AG | N/A | |
Carlos Toledo | Alcon AG | N/A | |
Rebecca Rimel | Becton Dickinson And | 69 | |
Willard Overlock | Becton Dickinson And | 71 | |
Craig Barratt | Intuitive Surgical | 55 | |
Amy Ladd | Intuitive Surgical | N/A | |
Ignacio Lopez | Alcon AG | N/A | |
Leslie Ireland | Citigroup | 58 | |
Gavin Wates | Alcon AG | N/A | |
Claire Pomeroy | Becton Dickinson And | 65 | |
Edward DeGraan | Becton Dickinson And | 70 |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 |
Shandong Weigao Group Leadership Team
Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director | ||
Jia Li, Independent Non-Executive Director | ||
Miu Wong, Company Secretary | ||
Hong Ju, Vice-General Manager of the Production and Supply Chain | ||
Hua Zhang, Vice Chairman, General Manager, Compliance Officer and Chairman of Corporate Governance Committee | ||
Shu Zhou, Non-Executive Director | ||
Jian Gong, Executive Director | ||
Rinan Cong, CEO Director | ||
Yi Wang, Deputy General Manager of General Affairs and Executive Director | ||
Ming Fu, Independent Non-Executive Director | ||
Jin Cui, CFO | ||
Jinxia Wang, Independent Non-Executive Director | ||
Jin Wang, Independent Non-Executive Director | ||
Shili Ni, Ex Director | ||
Xiu Song, Head - Sales Department | ||
Wai Lo, Independent Non-Executive Director | ||
Yuk Chan, Head - Business Development & Investor Relations | ||
Xue Chen, Non-Executive Chairman of the Board | ||
Lie Xia, Executive Director | ||
De Zhou, Deputy General Manager - Blood Transfusion Division | ||
Xue Wu, Chief Officer | ||
Jing Long, Vice-General Manager of Marketing Management |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.22 % | |||
Current Valuation | 6.24 B | |||
Shares Outstanding | 4.52 B | |||
Shares Owned By Insiders | 46.39 % | |||
Shares Owned By Institutions | 24.74 % | |||
Price To Earning | 20.29 X | |||
Price To Book | 2.20 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shandong Weigao Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Shandong Weigao Group information on this page should be used as a complementary analysis to other Shandong Weigao's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Shandong Pink Sheet analysis
When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |